51.37
price down icon0.72%   -0.37
after-market After Hours: 51.37
loading
Tarsus Pharmaceuticals Inc stock is traded at $51.37, with a volume of 663.86K. It is down -0.72% in the last 24 hours and up +15.49% over the past month.
See More
Previous Close:
$51.74
Open:
$50.28
24h Volume:
663.86K
Relative Volume:
1.09
Market Cap:
$2.16B
Revenue:
$17.39M
Net Income/Loss:
$-135.89M
P/E Ratio:
-11.07
EPS:
-4.64
Net Cash Flow:
$-123.00M
1W Performance:
-1.89%
1M Performance:
+15.49%
6M Performance:
+56.19%
1Y Performance:
+41.32%
1-Day Range:
Value
$47.88
$51.63
1-Week Range:
Value
$47.88
$52.30
52-Week Range:
Value
$20.08
$57.28

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
Name
Tarsus Pharmaceuticals Inc
Name
Phone
(949) 409-9820
Name
Address
15440 LAGUNA CANYON ROAD, IRVINE
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TARS's Discussions on Twitter

Compare TARS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TARS
Tarsus Pharmaceuticals Inc
51.37 2.16B 17.39M -135.89M -123.00M -4.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-20-23 Initiated Goldman Neutral
Jul-18-23 Initiated William Blair Outperform
May-18-23 Initiated Guggenheim Buy
Aug-01-22 Initiated Barclays Overweight
Dec-21-21 Initiated H.C. Wainwright Buy
Nov-23-21 Initiated Oppenheimer Outperform
Nov-10-20 Initiated BofA Securities Buy
Nov-10-20 Initiated Jefferies Buy
Nov-10-20 Initiated Ladenburg Thalmann Buy
Nov-10-20 Initiated Raymond James Strong Buy
View All

Tarsus Pharmaceuticals Inc Stock (TARS) Latest News

pulisher
Mar 28, 2025

Fastest-Growing Public Cos. Ride Healthcare Boom - Orange County Business Journal

Mar 28, 2025
pulisher
Mar 27, 2025

Tarsus Pharmaceuticals CEO sells $300,000 in stock By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 26, 2025

Tarsus Pharmaceuticals CEO sells $300,000 in stock - Investing.com India

Mar 26, 2025
pulisher
Mar 23, 2025

Where are the Opportunities in (TARS) - Stock Traders Daily

Mar 23, 2025
pulisher
Mar 21, 2025

Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Tarsus Pharmaceuticals’ HR chief sells shares worth $321,323 - Investing.com India

Mar 21, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals’ general counsel sells $463,765 in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Tarsus Pharmaceuticals Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

Tarsus Pharmaceuticals completes $134.8M stock offering By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Tarsus Pharmaceuticals completes $134.8M stock offering - Investing.com India

Mar 18, 2025
pulisher
Mar 14, 2025

Tarsus prices $125M stock offering - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

Tarsus Pharma dips after upsized $125 mln stock offering - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Tarsus Pharmaceuticals Prices Upsized $125 Million Equity Offering -March 13, 2025 at 03:44 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 12, 2025

Tarsus Pharmaceuticals launches $100 million stock offering - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Secures Massive $125M Capital Raise as Investors Rush Into Upsized Offering - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Announces Pricing Of Upsized $125 Million Public Offering -March 12, 2025 at 09:50 pm EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Pharmaceuticals dips on planned $100 million equity raise - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Pharmaceuticals launches $100 million stock offering By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Announces Proposed $100.0 Million Public Offering - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

Tarsus Pharma: Strong Execution In Xdemvy Commercialization (NASDAQ:TARS) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 10, 2025

Oppenheimer & Co. Inc. Takes Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 5.8% Following Analyst Upgrade - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Contrasting PharmaCyte Biotech (OTCMKTS:PMCBD) & Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Tarsus to Participate in Upcoming Investor Conference - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Tarsus Pharmaceuticals Inc (TARS) to Participate in Barclays Global Healthcare Conference - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

Healthcare Spotlight: Tarsus Takes Center Stage at Major Barclays Conference - StockTitan

Mar 06, 2025

Tarsus Pharmaceuticals Inc Stock (TARS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):